KANE BIOTECH
Kane Biotech Inc., a biotechnology company, engages in the research and development of products to prevent and disperse biofilms in medical and industrial applications. Its products include ALEDEX, an antimicrobial/antibiofilm composition comprising protamine sulfate and chlorhexidine, with applications in anti-infective medical device coatings, animal care and dairy, and food processing industries; DispersinB, an antibiofilm enzyme that inhibits, as well as disperses microbial biofilms, with applications in wound care, medical devices, oral care, and animal healthcare; and a toothpaste and mouthwash additive based on competence stimulating peptide technology for preventing and dispersing dental plaque biofilms. The company was founded in 2001 and is headquartered in Winnipeg, Canada.
KANE BIOTECH
Industry:
Biotechnology Health Care Medical
Founded:
2001-01-01
Address:
Winnipeg, Manitoba, Canada
Country:
Canada
Website Url:
http://www.kanebiotech.com
Total Employee:
1+
Status:
Active
Contact:
2044531314
Email Addresses:
[email protected]
Total Funding:
22.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Pivot Financial Inc
Pivot Financial Inc investment in Post-IPO Debt - Kane Biotech
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Kane Biotech
Government of Canada
Government of Canada investment in Grant - Kane Biotech
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Grant - Kane Biotech
Government of Canada
Government of Canada investment in Grant - Kane Biotech
Western Economic Diversification Canada
Western Economic Diversification Canada investment in Post-IPO Debt - Kane Biotech
Manitoba
Manitoba investment in Grant - Kane Biotech
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Grant - Kane Biotech
Genesys Venture
Genesys Venture investment in Pre Seed Round - Kane Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-05 | Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer |
Official Site Inspections
http://www.kanebiotech.com
- Host name: cloudproxy10018.sucuri.net
- IP address: 192.124.249.18
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
